EA201992421A1 - Способ получения озанимода - Google Patents

Способ получения озанимода

Info

Publication number
EA201992421A1
EA201992421A1 EA201992421A EA201992421A EA201992421A1 EA 201992421 A1 EA201992421 A1 EA 201992421A1 EA 201992421 A EA201992421 A EA 201992421A EA 201992421 A EA201992421 A EA 201992421A EA 201992421 A1 EA201992421 A1 EA 201992421A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ozanimoda
obtaining
new
ozanimod
preparation
Prior art date
Application number
EA201992421A
Other languages
English (en)
Inventor
Марта Порч-Маккаи
Дьюла Шимиг
Эникё Мольнар
Янош Петё
Балаж Вольк
Ласло Славик
Эва Сабо
Юдит Халас
Original Assignee
Эгиш Дьёдьсердьяр Зрт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш Дьёдьсердьяр Зрт. filed Critical Эгиш Дьёдьсердьяр Зрт.
Publication of EA201992421A1 publication Critical patent/EA201992421A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Настоящее изобретение относится к новому способу получения озанимода указанной формулы и его солей присоединения кислоты посредством новых промежуточных соединений и к новой полиморфной форме озанимода основания.
EA201992421A 2017-05-22 2018-05-18 Способ получения озанимода EA201992421A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP1700216 2017-05-22
PCT/HU2018/050019 WO2018215807A1 (en) 2017-05-22 2018-05-18 Process for the production of ozanimod

Publications (1)

Publication Number Publication Date
EA201992421A1 true EA201992421A1 (ru) 2020-03-27

Family

ID=89720175

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992421A EA201992421A1 (ru) 2017-05-22 2018-05-18 Способ получения озанимода

Country Status (11)

Country Link
US (1) US20200087269A1 (ru)
EP (1) EP3630738B1 (ru)
CN (1) CN110997645B (ru)
EA (1) EA201992421A1 (ru)
ES (1) ES2960051T3 (ru)
HR (1) HRP20231308T1 (ru)
MA (1) MA48798B1 (ru)
PL (1) PL3630738T3 (ru)
PT (1) PT3630738T (ru)
SI (1) SI3630738T1 (ru)
WO (1) WO2018215807A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019094409A1 (en) * 2017-11-07 2019-05-16 Teva Pharmaceuticals International Gmbh Salts and solid state forms of ozanimod
EP3891133B1 (en) * 2018-12-07 2023-06-07 Synthon B.V. Improved process for preparing ozanimod
WO2020152718A1 (en) * 2019-01-25 2020-07-30 Mylan Laboratories Limited Polymorphic forms 5-[3-[(1s)-2,3-dihydro-1-[(2-hydroxyethyl) amino]-1h-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)benzonitrile
CN112062785B (zh) * 2019-06-11 2023-06-27 广东东阳光药业有限公司 奥扎莫德及其中间体的制备方法
EP3999495A1 (en) 2019-07-16 2022-05-25 Synthon B.V. Improved process for preparing ozanimod
TW202131921A (zh) 2019-10-31 2021-09-01 瑞士商愛杜西亞製藥有限公司 Cxcr7拮抗劑與s1p1受體調節劑之組合
WO2021197852A1 (en) * 2020-04-02 2021-10-07 Synthon B.V. Crystalline form of ozanimod hydrochloride
EP4212156A1 (en) 2022-01-13 2023-07-19 Abivax Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2776242C (en) * 2009-10-08 2014-09-02 Sanofi Phenyloxadiazole derivatives as pgds inhibitors
WO2011060392A1 (en) * 2009-11-13 2011-05-19 Receptos, Inc. Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
WO2015066515A1 (en) * 2013-11-01 2015-05-07 Receptos, Inc. Selective sphingosine 1 phosphate receptor modulators and combination therapy therewith
WO2017215617A1 (zh) * 2016-06-14 2017-12-21 苏州科睿思制药有限公司 奥扎莫德的晶型、其盐酸盐的晶型及其制备方法
CN109563059A (zh) * 2016-08-19 2019-04-02 苏州科睿思制药有限公司 奥扎莫德的晶型及其制备方法
US11117875B2 (en) * 2016-09-14 2021-09-14 Hangzhou Solipharma Co., Ltd. Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod
JP7086945B2 (ja) * 2016-09-29 2022-06-20 レセプトス・リミテッド・ライアビリティ・カンパニー 狼瘡を処置するための化合物および方法

Also Published As

Publication number Publication date
EP3630738A4 (en) 2021-03-10
EP3630738A1 (en) 2020-04-08
HRP20231308T1 (hr) 2024-04-26
CN110997645B (zh) 2023-10-10
ES2960051T3 (es) 2024-02-29
PL3630738T3 (pl) 2024-04-08
CN110997645A (zh) 2020-04-10
WO2018215807A1 (en) 2018-11-29
MA48798B1 (fr) 2023-10-31
MA48798A (fr) 2020-04-08
PT3630738T (pt) 2023-10-24
SI3630738T1 (sl) 2024-02-29
EP3630738B1 (en) 2023-07-19
US20200087269A1 (en) 2020-03-19

Similar Documents

Publication Publication Date Title
EA201992421A1 (ru) Способ получения озанимода
EA201890522A1 (ru) Способ получения противогрибковых соединений
EA201692193A1 (ru) Способы получения ингибитора jak1 и его новых форм
CY1119731T1 (el) Διαδικασια για την παρασκευη παραγωγων χολικου οξεος
NZ726356A (en) Processes for preparing antiviral compounds
EA201792067A1 (ru) Противогрибковые соединения и способы получения
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
EA201691649A1 (ru) Способ получения противогрибковых соединений
EA201691648A1 (ru) Способ получения противогрибковых соединений
EA201791466A1 (ru) Способы получения соединений бензохинолина
EA201891770A1 (ru) Малеатная соль агониста tlr7, ее кристаллические формы c, d и e, способы получения и применение малеатной соли и кристаллических форм
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
EA201892515A1 (ru) Стероидные 6,7-бета-эпоксиды в качестве интермедиатов
EA201891769A1 (ru) СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ ПИРРОЛО[3,2-d]ПИРИМИДИНА И ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
CY1120763T1 (el) Νεες ενωσεις σουλφονυλαμινοβενζαμιδιου
CL2020001589A1 (es) Proceso para la preparación de derivados de quinolina.
CL2018002756A1 (es) Un proceso mejorado para la preparación de tartrato de butorfanol.
BR112019025028A2 (pt) Método para preparar um composto.
BR112016029510A2 (pt) métodos para a preparação de um composto, e, composto intermediário.
EA202091259A1 (ru) Способ получения опикапона и его интермедиатов
EA201391123A1 (ru) Способы получения соединений, являющихся пролекарствами ингибиторов присоединения вируса вич, и их интермедиатов
CY1118945T1 (el) Μεθοδος και ενδιαμεσα για την παρασκευη πρεγκαμπαλινης
EA201791645A1 (ru) Новые соли и полиморфы scy-078
EA201691362A1 (ru) Способы получения конденсированных гетероциклических модуляторов ионных каналов
EA202192840A1 (ru) Способ получения соединений карбамоилоксиметилтриазолциклогексиловой кислоты